AzTrials
AzTrials

High Intellectual PotentialMOHPINCT03128125

Study of Gesture and Executive Functions in Children With High Intellectual Potential

A study testing clinical examination in neurology, neuropsychological examination and anamnestic elements in people with High Intellectual Potential and Children, run by University Hospital, Brest at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The main objective of this study is to determine whether children with high intellectual potential have gestural and / or executive difficulties compared to control children. Read more about this study

Who is it for?
Ages 6 to 16 yearsHealthy volunteers can take part
Conditions the study is for
High Intellectual Potential, Children
What is being tested?
clinical examination in neurology, neuropsychological examination and anamnestic elements
Could I receive a placebo?
No, everyone receives an active treatment
How many people
66 participants
Where
1 siteFrance
Study dates
6 Apr 2017to 22 Aug 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 16 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • All participants :
  • Informed consent of the child and both parents obtained
  • Affiliated to Social Security
  • Participants must be between 6 and 16 years of age.
  • Child with high intellectual potential :
  • Score ≥ 130 on an intellectual efficiency scale administered by a psychologist
Show all 10Show fewer
  • Control child :
  • They will have to be intellectually efficient in the standard. To ensure this, the two sub-tests of the Intellectual Efficiency Scale (WISC-V) most closely correlated with intelligence (Vocabulary and Matrices) will be administered to them. Thus, the child must meet one of the following criteria in order to be included:
  • Have two standard notes between -1 and +1 DS (between 7 and 13);
  • Have one of its two notes between -1 and + 1DS (between 7 and 13) and the other between -2DS and <+ 2DS (between 5 and 15).

Who cannot join

  • All participants :
  • Neurological history (epilepsy, cranial trauma, prematurity ...)
  • Psychiatric history (Autistic Spectrum Disorder ...),
  • Known genetic disease,
  • Motor deficiency (eg hemiplegia),
  • Elementary sensory disorder (auditory and visual) or insufficient command of French, limiting the understanding and participation in the study likely to impact the results to the protocol.
Show all 12Show fewer
  • Gnosic visual or linguistic deficiency.
  • Sensory disorder
  • Psychotropic Intake
  • Control child :
  • High intellectual potential
  • Known or suspected learning disability (no dyslexia-dysorthography, dysphasia, dyspraxia, dyscalculia).

Trial locations and contacts

1 site in 1 country.

France1 site
  • University Hospital

    Brest, 29200

Other trials in France

About this study

The main objective of this study is to determine whether children with high intellectual potential have gestural and / or executive difficulties compared to control children.

Being tested
clinical examination in neurology, neuropsychological examination, anamnestic elements

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • clinical examination in neurologyOther

    This examination is based on the movement of the child in a standing position (forward and backward on a straight line, jumping on a foot ...), seated (visual continuation ...) and elongated (tone, patellar and achillian reflexes, superficial sensitivity ...) . This makes it possible to evaluate all the neurological systems.

  • neuropsychological examinationOther

    This examination is based on the use of standardized psychometric tools and validated with children, usually used in clinical practice.

  • anamnestic elementsOther

    Several elements will be collected during the clinical interview to inform the history of the child's development, such as neonatal data (term of pregnancy, APGAR score ...), age of appearance of the first words , seating, walking, possible care, level of education ans level of education of the parents.

Study groups in NCT03128125
Study groupRoleWhat they receive
High intellectual potentialExperimentalParticipation in the study involves the conduct of a clinical examination in neurology, the collection of anamnestic elements and a neuropsychological examination in children with high intellectual potential.
Receives: Other: clinical examination in neurology; Other: neuropsychological examination; Other: anamnestic elements
ControlOtherParticipation in the study involves the conduct of a clinical examination in neurology, the collection of anamnestic elements and a neuropsychological examination in control children with no particularities.
Receives: Other: clinical examination in neurology; Other: neuropsychological examination; Other: anamnestic elements

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Neuropsychological assessment

    Determine whether children with high intellectual potential have gestural and / or executive difficulties compared to control children with WISC-V scale (Wechsler).

    Measured: 1 day

  2. Neurological assessments

    Dysfunction (yes/no) for children with high intellectual potential compared to control children.

    Measured: 1 day

  3. Neuropsychological assessment

    Determine whether children with high intellectual potential have gestural and / or executive difficulties compared to control children. With Purdue Pegboard test.

    Measured: 1 day

  4. Neuropsychological assessment

    Determine whether children with high intellectual potential have gestural and / or executive difficulties compared to control children. With subtest Fluence Verbale (NEPSY-II)

    Measured: 1 day

  5. Neuropsychological assessment

    Determine whether children with high intellectual potential have gestural and / or executive difficulties compared to control children. With subtest of motricity (NEPSY-II)

    Measured: 1 day

  6. Neuropsychological assessment

    Determine whether children with high intellectual potential have gestural and / or executive difficulties compared to control children. With Rey test

    Measured: 1 day

  7. Neuropsychological assessment

    Determine whether children with high intellectual potential have gestural and / or executive difficulties compared to control children. With writing test (BHK)

    Measured: 1 day

  8. Neuropsychological assessment

    Determine whether children with high intellectual potential have gestural and / or executive difficulties compared to control children. With New card sorting test

    Measured: 1 day

  9. Neuropsychological assessment

    Determine whether children with high intellectual potential have gestural and / or executive difficulties compared to control children. With comportemental scale (BRIEF)

    Measured: 1 day

  10. Neuropsychological assessment

    Determine whether children with high intellectual potential have gestural and / or executive difficulties compared to control children. With M-ABC-II questionary

    Measured: 1 day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Apr 2017
  2. Study start6 Apr 2017
  3. Primary completion22 Aug 2018
  4. Study completion22 Aug 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Non-randomised
Intervention model
Parallel groups
Model description
Case-control study, monocentric.
Masking
None (open label)
Enrolment
66 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03128125
Sponsor's protocol ID
MOHPI (RB 16.145)
Acronym
MOHPI
Status last verified
Oct 2020
First submitted
22 Mar 2017
Last updated
5 Oct 2020
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing clinical examination in neurology, neuropsychological examination and anamnestic elements in people with High Intellectual Potential and Children, run by University Hospital, Brest at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 10 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 Oct 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Neuropsychological assessment (time frame: 1 day). The study lists 10 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Oct 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in